HIV Peptides That Inhibit Infection
Author Information
Author(s): Chertov Oleg, Zhang Ning, Chen Xin, Oppenheim Joost J., Lubkowski Jacek, McGrath Connor, Sowder Raymond C. II, Crise Bruce J., Malyguine Anatoli, Kutzler Michele A., Steele Amber D., Henderson Earl E., Rogers Thomas J.
Primary Institution: National Cancer Institute at Frederick
Hypothesis
The region of HIV-1 gp120 may directly interact with chemokine receptors similarly to chemokines.
Conclusion
The synthesized peptides derived from HIV-1 gp120 can inhibit HIV-1 infection in cell cultures.
Supporting Evidence
- Peptides 15K and 15D significantly reduced HIV-1 infection in a dose-dependent manner.
- The scrambled peptide 15KS did not inhibit virus infectivity, highlighting the importance of the specific amino acid sequence.
- Peptides exhibited inhibitory activities comparable to the chemokine CCL4.
Takeaway
Scientists created special pieces of HIV protein that can stop the virus from infecting cells, which could help in making new treatments.
Methodology
The study involved synthesizing peptides based on the HIV-1 gp120 sequence and testing their ability to inhibit HIV-1 infection in various cell types.
Limitations
The peptides showed low affinity for chemokine receptors, which may limit their effectiveness.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website